IDXX
IDEXX Laboratories, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website idexx.com
- Employees(FY) 11000
- ISIN US45168D1046
Performance
+0.09%
1W
+2.58%
1M
+26.75%
3M
+19.56%
6M
+26.43%
YTD
+3.28%
1Y
Profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Technical Analysis of IDXX 2025-06-13
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-06-05 07:00
- 2025-03-27 11:50
ClearBridge Mid Cap Growth Portfolios Q4 2024 Commentary(Seekingalpha)
- 2025-03-27 04:16
- 2025-03-26 23:13
- 2025-03-26 21:21
- 2025-03-25 00:36
- 2025-03-19 18:40
Invesco Global Focus Fund Q4 2024 Commentary(Seekingalpha)
- 2025-03-18 02:50
Analyst Report: IDEXX Laboratories, Inc.(Yahoo Finance)
- 2025-03-13 03:08
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory(Yahoo Finance)
- 2025-03-12 21:28
Corporate Buyers Sign Deals With Texas Solar Energy Projects(Yahoo Finance)
- 2025-03-11 07:22
Analyst Report: IDEXX Laboratories, Inc.(Yahoo Finance)
- 2025-03-05 22:30
- 2025-02-19 22:15
- 2025-02-18 07:50
- 2025-02-14 08:27
- 2025-02-14 01:00
- 2025-02-13 14:00
- 2025-02-12 07:58
Here’s Why IDEXX Laboratories (IDXX) Declined in Q4(Insider Monkey)
- 2025-02-10 17:08
- 2025-02-10 09:39
- 2025-02-10 09:15
- 2025-02-06 18:09
Why Idexx Labs Stock Rocketed Higher This Week(Yahoo Finance)
- 2025-02-04 19:00
IDXX: Raising target price to $488.00(Argus Research)
- 2025-02-04 16:40
- 2025-02-04 07:06
- 2025-02-04 07:06
- 2025-02-04 07:05
- 2025-02-04 07:04
- 2025-02-04 02:02
- 2025-02-04 00:20
Q4 2024 IDEXX Laboratories Inc Earnings Call(Thomson Reuters StreetEvents)
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.